Aortic Aneurysm Market Analysis

  • Report ID: 5073
  • Published Date: Sep 11, 2025
  • Report Format: PDF, PPT

Aortic Aneurysm Market Segmentation:

Type Segment Analysis

The abdominal aortic aneurysm segment is projected to gain the biggest share of 90% over the forecasted time range. AAA is a life-threatening condition that is observed among the most prevalent site of the true arterial aneurysm, causing up to 150.0% increase in the average size of the healthy aorta (2025 NLM article). As per a study published by ScienceDirect in April 2021, the global prevalence of this sub-type ranged between 2.0% and 12.0%, which occurred among 8.0% of men aged 65 and over. On the other hand, a 2024 report from the Cleveland Clinic mentioned that over 75.0% of all AAs is originated from abdominal aortic aneurysm. These conclusions signify the predominant captivity of this segment on incidence and severity, making it a priority for pioneers in the market.

Product Type Segment Analysis

The stent grafts segment is estimated to account for 84.2% of the aortic aneurysm market revenue by 2035. This instrument is widely used for endovascular aneurysm restorations, which has become a first-line minimally invasive treatment for AA. In addition, the availability of option for customization by using measurements from CT scan makes them more desired by surgeons. This

Our in-depth analysis of the global aortic aneurysm market includes the following segments:

      Type

  • Abdominal Aortic Aneurysm (AAA)
  • Thoracic Aortic Aneurysm (TAA)

      Product Type

  • Stent Grafts
  • Catheters

     Treatment Type

  • Open Surgical Repair (OSR)
  • Endovascular Aneurysm Repair (EVAR)
 

Browse key industry insights with market data tables & charts from the report:

Frequently Asked Questions (FAQ)

In the year 2026, the industry size of aortic aneurysm is evaluated at USD 6.27 billion.

The global aortic aneurysm market size was worth over USD 5.71 billion in 2025 and is poised to grow at a CAGR of more than 10.9%, reaching USD 16.07 billion revenue by 2035.

The North America aortic aneurysm market is projected to capture a 40% share by 2035, driven by top-tier healthcare and R&D on innovative AA treatments.

Key players in the market include Medtronic, W. L. Gore & Associates, Inc., MicroPort Scientific Corporation, Terumo Corporation, Endologix LLC, Boston Scientific Corporation, Japan Lifeline Co., Ltd.
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos